1 |
Polybenzimidazole for Active Pharmaceutical Ingredient Purification: The Mometasone Furoate Case Study Ferreira FA, Esteves T, Carrasco MP, Bandarra J, Afonso CAM, Ferreira FC Industrial & Engineering Chemistry Research, 58(24), 10524, 2019 |
2 |
Screening commercial available resins for simultaneous removal of two potential genotoxins from API methanolic streams Esteves T, Ferreira FA, Pina M, Bandarra J, Ferreira FC Separation Science and Technology, 54(18), 3005, 2019 |
3 |
Molecularly imprinted polymer strategies for removal of a genotoxic impurity, 4-dimethylaminopyridine, from an active pharmaceutical ingredient post-reaction stream Esteves T, Viveiros R, Bandarra J, Heggie W, Casimiro T, Ferreira FC Separation and Purification Technology, 163, 206, 2016 |
4 |
A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea Szekely G, Bandarra J, Heggie W, Sellergren B, Ferreira FC Separation and Purification Technology, 86, 79, 2012 |
5 |
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions Szekely G, Bandarra J, Heggie W, Ferreira FC, Sellergren B Separation and Purification Technology, 86, 190, 2012 |
6 |
Organic solvent nanofiltration: A platform for removal of genotoxins from active pharmaceutical ingredients Szekely G, Bandarra J, Heggie W, Sellergren B, Ferreira FC Journal of Membrane Science, 381(1-2), 21, 2011 |